Buyers within the funding spherical included Lightspeed Enterprise Companions, CVS Well being Ventures, Redpoint Enterprise and NVentures – Nvidia’s enterprise capital arm.
- Up to date On Feb 18, 2025 at 06:47 AM IST
Learn by: 100 Business Professionals
Learn by 100 Business Professionals
Bengaluru: Abridge, a startup that makes use of synthetic intelligence to construct medical paperwork, mentioned on Monday it raised $250 million in a funding round co-led by Elad Gil and IVP.
Buyers within the funding spherical included Lightspeed Enterprise Companions, CVS Well being Ventures, Redpoint Enterprise and NVentures – Nvidia’s enterprise capital arm.
AI startups captured a report 46.4per cent of the entire $209 billion raised by U.S. startups in 2024, in contrast with lower than 10per cent a decade earlier.
Abridge didn’t disclose the valuation at which the quantity was raised. The corporate was valued at $850 million after a funding spherical final 12 months, through which it had raised $150 million.
Pittsburgh-based Abridge, based in 2018, automates scientific notes and medical conversations for medical doctors, leveraging synthetic intelligence.
“AI may be transformative by abstracting away the complexity and guidelines round income cycle because it pertains to documentation, permitting clinicians to give attention to their sufferers whereas getting their documentation proper the primary time,” Somesh Sprint, Normal Accomplice at IVP, mentioned in a press release.
Abridge’s merchandise have been applied at about 100 healthcare techniques within the U.S., together with rural setups and kids’s hospitals.
The healthcare startup mentioned that the most recent funding will assist it develop AI capabilities and develop commercially.
(Reporting by Pritam Biswas in Bengaluru; Modifying by Susan Fenton)
- Revealed On Feb 18, 2025 at 06:28 AM IST